Not yet recruitingPhase 2NCT07055880

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Studying Rabies

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sinovac Biotech Co., Ltd
Principal Investigator
Ali Faisal Saleem, D.O
Vice Chair, Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan
Intervention
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried(biological)
Enrollment
120 target
Eligibility
18-59 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07055880 on ClinicalTrials.gov

Other trials for Rabies

Additional recruiting or active studies for the same condition.

See all trials for Rabies →

← Back to all trials